A Portfolio Model of Drug Development for Tuberculosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Portfolio Model of Drug Development for Tuberculosis

Published:2006-03-03 Issue:5765 Volume:311 Page:1246-1247
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Glickman Seth W.¹,Rasiel Emma B.²,Hamilton Carol Dukes³,Kubataev Arsen⁴,Schulman Kevin A.¹⁵⁶

Affiliation:

1. Health Sector Management Program, The Fuqua School of Business

2. Department of Economics, Duke University, Durham, NC 27708, USA.

3. Division of Infectious Diseases

4. American International Health Alliance, Moscow 125047, Russia.

5. Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.

6. Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference16 articles.

1. The Growing Burden of Tuberculosis

2. World Health Organization (WHO) Tuberculosis fact sheet no. 104 (WHO Geneva 2005); (www.who.int/mediacentre/factsheets/fs104/en/).

3. Multidrug-resistant tuberculosis

4. Multidrug-resistant tuberculosis—can the tide be turned?

5. Health and economic benefits of an accelerated program of research to combat global infectious diseases

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of Various Rifampicin Analogs against Mycobacterium tuberculosis and their Drug Interactions;Medicinal Chemistry;2023-10-05

2. Study of Structurally Diverse Currently Used and Recently Developed Antimycobacterial Drugs;Medicinal Chemistry;2023-08

3. Exploring Azatidinone Moiety: An Insight into its Anti-tubercular Potency;Drug Research;2021-05-25

4. Analysis of the health product pipeline for poverty-related and neglected diseases using the Portfolio-to-Impact (P2I) modeling tool;F1000Research;2020-05-21

5. Recent Developments in Azole Compounds as Antitubercular Agent;Mini-Reviews in Organic Chemistry;2019-01-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3